Phase 3 N=623 Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Diabetic Neuropathy, Painful
Primary: Baseline Mean Pain Score — 6.65; 6.67 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=452 Safety and Efficacy of Gabapentin in Postherpetic Neuralgia
Neuralgia,Postherpetic
Primary: Mean Change in Baseline Observation Carried Forward (BOCF) Average Daily Pain Score — -2.12; -1.63 Scores on a scale — p=0.0125
Phase 2 N=79 Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia
Postherpetic Neuralgia
Primary: Change From Baseline (Week 2 of the Run-in Period) in Average Daily Pain Score (ADPS) — -1.62; -2.42 score on a scale — p=0.120
Phase 3 N=372 A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
Neuralgia, Postherpetic
Primary: Mean Pain Scores at Endpoint — 5.12; 4.81; 4.26; 4.49 score on scale — p=0.262
Phase 2 N=91 A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia
Pain · Diabetic Neuropathies · Neuralgia
Primary: Change From Baseline in Average Numerical Rating Scale (NRS) Score at Week 12 — 6.7; 6.9; -2.6; -2.6 Units on a scale
Phase 2 N=294 A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia
Neuralgia, Postherpetic
Primary: Change From Baseline in the Average Pain Intensity Score at Week 12 — 6.13; 6.04; 6.05; -1.42 Score on a scale
Phase 2 N=70 A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)
Postherpetic Neuralgia
Primary: Change in Mean Daily Pain Score From Baseline to Week 3 (With LOCF) — -0.94; -0.97 units on a scale
Phase 4 N=222 Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)
Postherpetic Neuralgia ( PHN )
Primary: Baseline Mean Pain Score — 5.93; 6.08 units on a scale
Phase 2 N=360 A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
Post Herpetic Neuralgia · PHN · Neuropathy
Primary: Change in Pain Scores Comparing NP-1 Cream vs. Placebo Cream for Treatment of the Pain of Post Herpetic Neuralgia(PHN)From Baseline to 28 Days. — 2.424; 2.471; 1.877…
Phase 4 N=121 Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP
Diabetic Peripheral Neuropathic Pain (DPN) · Postherpetic Neuralgia (PHN) · HIV-related Neuropathic Pain (HIV)
Primary: Change From Baseline to End of Treatment (EOT) in Weekly Mean Pain Score on the Daily Pain Rating Scale (DPRS) — -3.8 scores on scale — p=< 0.0001
Phase 3 N=806 Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
Post Herpetic Neuralgia
Primary: Number of Participants With Loss of Therapeutic Response. — 29; 63 Participants — p=<0.0001
N/A N=20 Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia
Trigeminal Neuralgia
Primary: Average Number of Pain Attacks — 3.3533; 3.1807 Pain attacks
N/A N=80 Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery
Perioperative Chest Pain
Primary: Pain Disability Index Score (PDI) at Six Months Following Surgical Procedure — 26; 30; 12; 13 units on a scale — p=0.28
N/A N=81 Pulsed Radiofrequency vs. Steroid Injections for Occipital Neuralgia
Occipital Neuralgia
Primary: Change in Average Occipital Pain 6 Weeks After the Start of Treatment — 3.068; 3.738 units on a scale
Phase 3 N=256 Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
Neuropathic Pain
Primary: Neuropathic Pain in Subjects With Peripheral Neuropathic Pain Conditions During the Double-blind Phase — 2.84; 3.62 score on scale — p=0.0018